SCHEMBL1734839

SCHEMBL1734839

CC(C)(C)OC(=O)N(N)C(=O)C(=O)N(C[C]=O)C1CCCC1

nearest known ligand 0.36

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8707506 0.83 DPP4 (0.38) DPP4
SCHEMBL16106366 0.71 HSD11B1 (0.37) DPP4
SCHEMBL27510109 0.70 EPHX1 (0.39) DPP4
SCHEMBL574102 0.70 BTK (0.36) DPP4
SCHEMBL24577501 0.70 DPP4 (0.56) DPP4
SCHEMBL27623896 0.70 DPP4 (0.36) DPP4
SCHEMBL16200883 0.70 DPP4 (0.39) DPP4
SCHEMBL16265413 0.69 EPHX1 (0.35) DPP4
SCHEMBL7746771 0.69 DPP4 (0.36) DPP4
SCHEMBL871258 0.69 GAA (0.37) DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1605963-B1 INHIBITORS OF ANTIGEN PRESENTATION BY MHC CLASS II MOLECULES AND METHODS OF USE THEREOF PROVID PHARMACEUTICALS INC (US) 2011-11-16 EP disclosed
EP-1605963-A4 INHIBITORS OF ANTIGEN PRESENTATION BY MHC CLASS II MOLECULES AND METHODS OF USE THEREOF PROVID PHARMACEUTICALS INC (US) 2007-02-14 EP disclosed
EP-1605963-A2 INHIBITORS OF ANTIGEN PRESENTATION BY MHC CLASS II MOLECULES AND METHODS OF USE THEREOF Provid Pharmaceuticals, Inc. (US) 2005-12-21 EP disclosed
WO-2004073625-A2 INHIBITORS OF ANTIGEN PRESENTATION BY MHC CLASS II MOLECULES AND METHODS OF USE THEREOF PROVID PHARMACEUTICALS, INC. (US) 2004-09-02 WO disclosed